SKI Market

A+| A| A-|

Indian Indices

Sensex

78,136.76 949.89
( 1.23%)

Global Indices

Nasdaq

52,569.33 -110.31
(-0.21%)

Dow Jones

7,555.54 -37.86
(-0.50%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,555.24 39.32
(0.37%)

Forex

USD-INR

96.26 0.11
(0.12%)

EUR-INR

110.12 0.41
(0.38%)

GBP-INR

129.49 0.88
(0.69%)

JPY-INR

0.59 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aravali Securities & Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

512344

INE068C01015

-0.7290145

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ARAVALISEC

5.74

EPS(TTM)

Face Value()

Div & Yield %

Back

Bafna Pharmaceuticals standalone net profit rises 93.68% in the December 2025 quarter

Feb 12,2026

Net profit of Bafna Pharmaceuticals rose 93.68% to Rs 1.84 crore in the quarter ended December 2025 as against Rs 0.95 crore during the previous quarter ended December 2024. Sales rose 15.37% to Rs 38.29 crore in the quarter ended December 2025 as against Rs 33.19 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	38.29	33.19	15
OPM %	7.97	9.25	-
PBDT	3.41	2.62	30
PBT	1.84	0.96	92
NP	1.84	0.95	94

78,136.76 949.89 ( 1.23%)

52,569.33 -110.31 (-0.21%)

7,555.54 -37.86 (-0.50%)

63,887.74 -2,947.80 (-4.41%)

10,555.24 39.32 (0.37%)

96.26 0.11 (0.12%)

110.12 0.41 (0.38%)

129.49 0.88 (0.69%)

0.59 0.00 (0.14%)